/Insulet%20Corporation%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Acton, Massachusetts-based Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company has a market cap of $13.4 billion and offers Omnipod platform products, including the Omnipod 5 automated insulin delivery system, Omnipod DASH insulin management system, and the Omnipod Insulin Management System.
PODD is expected to release its Q1 2026 earnings on Wednesday, May 6, before the market opens. Ahead of the event, analysts expect the company’s EPS to be $1.14 on a diluted basis, up 11.8% from $1.02 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.